Thermal sensitization through ROS modulation: A strategy to improve the efficacy of hyperthermic intraperitoneal chemotherapy

Surgery

Volumn 142, Issue 3, 2007, Pages 384-392

  Wang, Chia Chi ^a   Chen, Fei ^a   Kim, Eugene ^a   Harrison, Lawrence E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2,2' AZOBIS(2 AMIDINOPROPANE); 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AZO COMPOUND; HEAT SHOCK PROTEIN 27; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; TROLOX C; UO 126;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; FLUORESCENCE; HEAT; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; TEMPERATURE; WESTERN BLOTTING;

AMIDINES; CACO-2 CELLS; CELL DEATH; CELL SURVIVAL; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HT29 CELLS; HUMANS; HYPERTHERMIA, INDUCED; OXIDANTS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES;

EID: 34548124704     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.03.013     Document Type: Article

References (39)

1. Carraro P.G., Segala M., Cesana B.M., and Tiberio G. Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rect 44 (2001) 243-250
2. Jayne D.G., Fook S., Loi C., and Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 (2002) 1545-1550
3. Elias D., Blot F., El Otmany A., Antoun S., Lasser P., Boige V., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
4. Loggie B.W., Fleming R.A., McQuellon R.P., Russel G.B., and Geisinger K.R. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66 (2000) 561-568
5. Shen P., Levine E.A., Hall J., Case D., Russell G., Fleming R., et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138 (2003) 26-33
6. Verwaal V.J., van Ruth S., de Bree E., van Sloothen G.W., van Tinteren H., Boot H., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
7. Lepock J.R. How do cells respond to their thermal environment?. Int J Hypertherm 21 (2005) 681-687
8. Krishna M.C., Dewhirst M.W., Friedman H.S., Cook J.A., De Graff W., Samuni T.A., et al. Hyperthermic sensitization by the radical initiator 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH). I. In vitro studies. Internat J Hypertherm 10 (1994) 271-281
9. Yuki H., Kondo T., Zhao Q.L., Fujiwara Y., Tanabe K., Ogawa R., et al. A free radical initiator, 2,2′-azobis (2-aminopropane) dihydrochloride enhances hyperthermia-induced apoptosis in human uterine cervical cancer cell lines. Free Radical Res 37 (2003) 631-643
10. Rosenkranz A.R., Schmaldienst S., Stuhlmeier K.M., Chen W., Knapp W.G., and Zlabinger J. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. J Immunol Meth 156 (1992) 39-45
11. Hildebrandt B., Wust P., Ahlers O., Dieing A., Sreenivasa G., Kerner T., et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol-Hematol 43 (2002) 33-56
12. Jacquet P., Stephens A.D., Averbach A.M., Chang D., Ettinghausen S.E., Dalton R.R., et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 77 (1996) 2622-2629
13. Arai Y., Kondo T., Tanabe K., Zhao Q.L., Li F.J., and Ogawa R. Enhancement of hyperthermia-induced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells. J Biol Chem 277 (2002) 18986-18993
14. Shchepotin I.B., Buras R.R., Nauta R.J., Shabahang M., and Evans S.R. Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma. Cancer Chemother Pharmacol 34 (1994) 257-260
15. Wachsberger P.R., Burd R., Bhala A., Bobyock S.B., Wahl M.L., Owen C.S., et al. Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia. Internat J Hypertherm 19 (2003) 507-519
16. Boonstra J., and Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337 (2004) 1-13
17. Davidson J.F., Whyte B., Bissinger P.H., and Schiestl R.H. Oxidative stress is involved in heat-induced cell death in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 93 (1996) 5116-5121
18. Flanagan S.W., Moseley P.L., and Buettner G.R. Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping. FEBS Lett 431 (1998) 285-286
19. Matsumoto H., Hayashi S., Hatashita M., Ohnishi K., Ohtsubo T., Kitai R., et al. Nitric oxide is an initiator of intercellular signal transduction for stress response after hyperthermia in mutant p53 cells of human glioblastoma. Cancer Res 59 (1999) 3239-3244
20. Rudin C.M., Yang Z., Schumaker L.M., VanderWheele D.J., Newkirk K., Egorin M.J., et al. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res 63 (2003) 312-318
21. Miller R.A., Woodburn K.W., Fan Q., Lee I., Miles D., Duran G., et al. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin. Clin Can Res 7 (2001) 3215-3221
22. Lebedeva I.V., Su Z.Z., Sarkar D., Gopalkrishnan R.V., Waxman S., Yacoub A., et al. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene 24 (2005) 585-596
23. McClain D.E., Kalinich J.F., and Ramakrishnan N. Trolox inhibits apoptosis in irradiated MOLT-4 lymphocytes. FASEB J 9 (1995) 1345-1354
24. Ramakrishnan N., McClain D.E., and Catravas G.N. Membranes as sensitive targets in thymocyte apoptosis. Internat J Radiat Biol 63 (1993) 693-701
25. Raspor P., Plesnicar S., Gazdag Z., Pesti M., Miklavcic M., Lah B., et al. Prevention of intracellular oxidation in yeast: the role of vitamin E analogue, Trolox (6-hydroxy-2,5,7,8-tetramethylkroman-2-carboxyl acid). Cell Biol Internat 29 (2005) 57-63
26. Yatvin M.B., and Cramp W.A. Role of cellular membranes in hyperthermia: some observations and theories reviewed. Internat J Hypertherm 9 (1993) 165-185
27. Matsuzawa A., and Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antiox Redox Signal 7 (2005) 472-481
28. Kim H.J., Chakravarti N., Oridate N., Choe C., Claret F.X., and Lotan R. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene 25 (2006) 2785-2794
29. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
30. Roulston A., Reinhard C., Amiri P., and Williams L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 273 (1998) 10232-10239
31. Nemoto S., Xiang J., Huang S., and Lin A. Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem 273 (1998) 16415-16420
32. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
33. Brand A., Gil S., Seger R., and Yavin E. Lipid constituents in oligodendroglial cells alter susceptibility to H2O2-induced apoptotic cell death via ERK activation. J Neurochem 76 (2001) 910-918
34. Wang X., Martindale J.L., and Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275 (2000) 39435-39443
35. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2 (2002) 489-501
36. Han H., Wang H., Long H., Nattel S., and Wang Z. Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 276 (2001) 26357-26364
37. Wang X., McCullough K.D., Franke T.F., and Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 275 (2000) 14624-14631
38. Landry J., Chretien P., Lambert H., Hickey E., and Weber L.A. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 109 (1989) 7-15
39. Samali A., and Cotter T.G. Heat shock proteins increase resistance to apoptosis. Experim Cell Res 223 (1996) 163-170